Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia

Exclusion Criteria

• •Patients with serious invasive candidiasis whose prognoses are considered to be poor (life expectancy judged to be less than 5 days).
• •Patients with severe complications in the liver
• •Pregnant or lactating women
• •Patients who have received at least 5 days of prior systemic treatment of fluconazole or echinocandin with no response.
• •Patients who have prior antifungal infection requiring treatment with systemic antifungal agents for conditions other than candidemia and invasive candidiasis.